Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors. - Le LHD; Feidler AM; Rodriguez LC; Cealie M; Plunk E; Li H; Kara-Pabani K; Lamantia C; O'Banion MK; Majewska AK (Brain, behavior, and immunity, 2025)